IBM Watson Turns Oncogenes Into Drug Targets

News   Aug 09, 2017 | Original story from Medical College of Georgia at Augusta University

 
IBM Watson Turns Oncogenes Into Drug Targets

Dr. Ravindra Kolhe, breast and molecular pathologist at the Medical College of Georgia at Augusta University

 
 
 

RELATED ARTICLES

Existing Diabetes Drug Could Lower Brain Pressure

News

A drug commonly used to treat patients with either obesity or Type II diabetes could be used as a novel new way to lower brain pressure.

READ MORE

Medivir Outsources Compound Management to BioAscent

News

BioAscent is now managing 56,000 samples of Medivir's compound collection for their ongoing drug discovery activities.

READ MORE

New Technique Overcomes Genetic Cause of Infertility

News

Scientists have created healthy offspring from genetically infertile male mice, offering a potential new approach to tackling a common genetic cause of human infertility.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Informatics & Automation

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE